✦ LIBER ✦

A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer

✍ Scribed by Kruczek, K; Ratterman, M; Tolzien, K; Sulo, S; Lestingi, T M; Nabhan, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib Has Moderate Single-agent Acti

✍ Chadi Nabhan; Timothy M. Lestingi; Angel Galvez; Kathy Tolzien; Susan K. Kelby; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 328 KB

126 Long term safety and efficacy in a r

✍ A.J. Armstrong; J.R. Gingrich; M Häggman; W.M. Stadler; J.E. Damber; L. Belkoff; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Lenalidomide Monotherapy in Chemotherapy

✍ Nabhan, Chadi; Patel, Anand; Villines, Dana; Tolzien, Kathy; Kelby, Susan K.; Le 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 263 KB

98 Combination therapy of peptide vaccin

✍ Uemura, H.; Kimura, T.; Yoshimura, K.; Minami, T.; Nozawa, M.; Nakagawa, T.; Fuj 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A randomized phase II efficacy and safet

✍ Arun A. Azad,Emma K. Beardsley,Sebastian J. Hotte… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 188 KB

A phase II study of sorafenib in combina

✍ Emma K. Beardsley, Sebastien J. Hotte, Scott North, Susan L. Ellard, Eric Winqui 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB